Your browser doesn't support javascript.
loading
A Historic Perspective and Overview of H-Ras Structure, Oncogenicity, and Targeting.
Shu, Lihua; Wang, Dongsheng; Saba, Nabil F; Chen, Zhuo G.
Afiliação
  • Shu L; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.
  • Wang D; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.
  • Saba NF; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia. gzchen@emory.edu nfsaba@emory.edu.
  • Chen ZG; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia. gzchen@emory.edu nfsaba@emory.edu.
Mol Cancer Ther ; 19(4): 999-1007, 2020 04.
Article em En | MEDLINE | ID: mdl-32241873
ABSTRACT
H-Ras is a unique isoform of the Ras GTPase family, one of the most prominently mutated oncogene families across the cancer landscape. Relative to other isoforms, though, mutations of H-Ras account for the smallest proportion of mutant Ras cancers. Yet, in recent years, there have been renewed efforts to study this isoform, especially as certain H-Ras-driven cancers, like those of the head and neck, have become more prominent. Important advances have therefore been made not only in the understanding of H-Ras structural biology but also in approaches designed to inhibit and impair its signaling activity. In this review, we outline historic and present initiatives to elucidate the mechanisms of H-Ras-dependent tumorigenesis as well as highlight ongoing developments in the quest to target this critical oncogene.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas p21(ras) / Terapia de Alvo Molecular / Mutação / Neoplasias Limite: Humans Idioma: En Revista: Mol Cancer Ther Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas p21(ras) / Terapia de Alvo Molecular / Mutação / Neoplasias Limite: Humans Idioma: En Revista: Mol Cancer Ther Ano de publicação: 2020 Tipo de documento: Article